Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Prepaid Assets: 2019-2025

Historic Prepaid Assets for Nurix Therapeutics (NRIX) over the last 5 years, with Aug 2025 value amounting to $11.8 million.

  • Nurix Therapeutics' Prepaid Assets rose 47.34% to $11.8 million in Q3 2025 from the same period last year, while for Aug 2025 it was $11.8 million, marking a year-over-year increase of 47.34%. This contributed to the annual value of $9.8 million for FY2024, which is 29.08% up from last year.
  • Nurix Therapeutics' Prepaid Assets amounted to $11.8 million in Q3 2025, which was up 11.61% from $10.5 million recorded in Q2 2025.
  • Nurix Therapeutics' 5-year Prepaid Assets high stood at $14.0 million for Q1 2025, and its period low was $3.7 million during Q1 2021.
  • Over the past 3 years, Nurix Therapeutics' median Prepaid Assets value was $8.8 million (recorded in 2023), while the average stood at $9.4 million.
  • As far as peak fluctuations go, Nurix Therapeutics' Prepaid Assets surged by 177.38% in 2022, and later plummeted by 37.62% in 2024.
  • Quarterly analysis of 5 years shows Nurix Therapeutics' Prepaid Assets stood at $9.2 million in 2021, then rose by 1.24% to $9.3 million in 2022, then decreased by 18.40% to $7.6 million in 2023, then grew by 29.08% to $9.8 million in 2024, then skyrocketed by 47.34% to $11.8 million in 2025.
  • Its Prepaid Assets was $11.8 million in Q3 2025, compared to $10.5 million in Q2 2025 and $14.0 million in Q1 2025.